{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:35:35Z","timestamp":1790804135375,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG17032"],"award-info":[{"award-number":["IG17032"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG25764"],"award-info":[{"award-number":["IG25764"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["19-0096"],"award-info":[{"award-number":["19-0096"]}],"id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2018-12368231"],"award-info":[{"award-number":["RF-2018-12368231"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2018-12368231"],"award-info":[{"award-number":["RF-2018-12368231"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003390","name":"Fritz Thyssen Stiftung","doi-asserted-by":"publisher","award":["10.23.1.012MN"],"award-info":[{"award-number":["10.23.1.012MN"]}],"id":[{"id":"10.13039\/501100003390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1279"],"award-info":[{"award-number":["CRC1279"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-68040-5","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T13:04:38Z","timestamp":1767099878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-6428","authenticated-orcid":false,"given":"Paolo G.","family":"Cocomazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Iatrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8350-484X","authenticated-orcid":false,"given":"Claudia","family":"Minici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gounari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Theresa","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0206-1862","authenticated-orcid":false,"given":"Can","family":"Akp\u0131naro\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5164-2877","authenticated-orcid":false,"given":"Marco","family":"Patrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9472-6854","authenticated-orcid":false,"given":"Luca","family":"Broggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4166-0438","authenticated-orcid":false,"given":"Michela","family":"Frenquelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3545-0330","authenticated-orcid":false,"given":"Ioannis","family":"Sarrigeorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4693-789X","authenticated-orcid":false,"given":"Peggy","family":"Lymberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8822-0141","authenticated-orcid":false,"given":"Georgios","family":"Petrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4435-3532","authenticated-orcid":false,"given":"Triantafyllia","family":"Koletsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Scarf\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8467-7945","authenticated-orcid":false,"given":"Andreas","family":"Agathangelidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3383-141X","authenticated-orcid":false,"given":"Hassan","family":"Jumaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3295-5859","authenticated-orcid":false,"given":"Palash C.","family":"Maity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-7342","authenticated-orcid":false,"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8529-640X","authenticated-orcid":false,"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0787-1883","authenticated-orcid":false,"given":"Massimo","family":"Degano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"68040_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.critrevonc.2016.06.003","volume":"104","author":"L Scarf\u00f2","year":"2016","unstructured":"Scarf\u00f2, L., Ferreri, A. J. M. & Ghia, P. Chronic lymphocytic leukaemia. Crit. Rev. Oncol. Hematol. 104, 169\u2013182 (2016).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"68040_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.critrevonc.2007.04.008","volume":"64","author":"P Ghia","year":"2007","unstructured":"Ghia, P., Ferreri, A. M. & Caligaris-Cappio, F. Chronic lymphocytic leukemia. Crit. Rev. Oncol. Hematol. 64, 234\u2013246 (2007).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"68040_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1172\/JCI118792","volume":"98","author":"DG Efremov","year":"1996","unstructured":"Efremov, D. G., Ivanovski, M., Batista, F. D., Pozzato, G. & Burrone, O. R. IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations. J. Clin. Invest 98, 290\u2013298 (1996).","journal-title":"J. Clin. Invest"},{"key":"68040_CR4","doi-asserted-by":"publisher","unstructured":"Jain, N., Wierda, W. G. & O\u2019Brien, S. Chronic lymphocytic leukaemia. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(24)00595-6 (2024).","DOI":"10.1016\/S0140-6736(24)00595-6"},{"key":"68040_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/17474086.2016.1199948","volume":"9","author":"N Jain","year":"2016","unstructured":"Jain, N. & Keating, M. J. Richter transformation of CLL. Expert Rev. Hematol. 9, 793\u2013801 (2016).","journal-title":"Expert Rev. Hematol."},{"key":"68040_CR6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","volume":"34","author":"JA Burger","year":"2013","unstructured":"Burger, J. A. & Chiorazzi, N. B cell receptor signaling in chronic lymphocytic leukemia. Trends Immunol. 34, 592\u2013601 (2013).","journal-title":"Trends Immunol."},{"key":"68040_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nrc.2017.121","volume":"18","author":"JA Burger","year":"2018","unstructured":"Burger, J. A. & Wiestner, A. Targeting B cell receptor signalling in cancer: preclinical and clinical advances. Nat. Rev. Cancer 18, 148\u2013167 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"68040_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41375-018-0303-x","volume":"33","author":"E Ten Hacken","year":"2019","unstructured":"Ten Hacken, E., Gounari, M., Ghia, P. & Burger, J. A. The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia. Leukemia 33, 287\u2013298 (2019).","journal-title":"Leukemia"},{"key":"68040_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa1400376","volume":"371","author":"JC Byrd","year":"2014","unstructured":"Byrd, J. C. et al. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N. Engl. J. Med. 371, 213\u2013223 (2014).","journal-title":"N. Engl. J. Med."},{"key":"68040_CR10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1470-2045(14)70335-3","volume":"15","author":"JA Burger","year":"2014","unstructured":"Burger, J. A. et al. Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study. Lancet Oncol. 15, 1090\u20131099 (2014).","journal-title":"Lancet Oncol."},{"key":"68040_CR11","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1158\/1078-0432.CCR-14-2225","volume":"21","author":"RA de Claro","year":"2015","unstructured":"de Claro, R. A. et al. FDA approval: ibrutinib for patients with previously treated mantle cell lymphoma and previously treated chronic lymphocytic leukemia. Clin. Cancer Res. 21, 3586\u20133590 (2015).","journal-title":"Clin. Cancer Res."},{"key":"68040_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1215637","volume":"369","author":"JC Byrd","year":"2013","unstructured":"Byrd, J. C. et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N. Engl. J. Med. 369, 32\u201342 (2013).","journal-title":"N. Engl. J. Med."},{"key":"68040_CR13","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1182\/bloodadvances.2021006434","volume":"6","author":"PM Barr","year":"2022","unstructured":"Barr, P. M. et al. Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia. Blood Adv. 6, 3440\u20133450 (2022).","journal-title":"Blood Adv."},{"key":"68040_CR14","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G. & Stevenson, F. K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94, 1848\u20131854 (1999).","journal-title":"Blood"},{"key":"68040_CR15","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","volume":"119","author":"A Agathangelidis","year":"2012","unstructured":"Agathangelidis, A. et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 119, 4467\u20134475 (2012).","journal-title":"Blood"},{"key":"68040_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","volume":"109","author":"K Stamatopoulos","year":"2007","unstructured":"Stamatopoulos, K. et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 109, 259\u2013270 (2007).","journal-title":"Blood"},{"key":"68040_CR17","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood.2020007039","volume":"137","author":"A Agathangelidis","year":"2021","unstructured":"Agathangelidis, A. et al. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. Blood 137, 1365\u20131376 (2021).","journal-title":"Blood"},{"key":"68040_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature11309","volume":"489","author":"M D\u00fchren-von Minden","year":"2012","unstructured":"D\u00fchren-von Minden, M. et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 489, 309\u2013312 (2012).","journal-title":"Nature"},{"key":"68040_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15746","volume":"8","author":"C Minici","year":"2017","unstructured":"Minici, C. et al. Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia. Nat. Commun. 8, 15746 (2017).","journal-title":"Nat. Commun."},{"key":"68040_CR20","doi-asserted-by":"publisher","unstructured":"Gemenetzi, K. et al. Higher order immunoglobulin repertoire restrictions in Cll: the illustrative case of stereotyped subsets #2 And #169. Blood https:\/\/doi.org\/10.1182\/blood.2020005216 (2020).","DOI":"10.1182\/blood.2020005216"},{"key":"68040_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ajh.23591","volume":"89","author":"I Del Giudice","year":"2014","unstructured":"Del Giudice, I. et al. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients\u2019 prognosis. Am. J. Hematol. 89, 74\u201382 (2014).","journal-title":"Am. J. Hematol."},{"key":"68040_CR22","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.3324\/haematol.2017.182634","volume":"103","author":"P Baliakas","year":"2018","unstructured":"Baliakas, P. et al. No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy. Haematologica 103, e158\u2013e161 (2018).","journal-title":"Haematologica"},{"key":"68040_CR23","doi-asserted-by":"publisher","first-page":"W382","DOI":"10.1093\/nar\/gki387","volume":"33","author":"J Schymkowitz","year":"2005","unstructured":"Schymkowitz, J. et al. The FoldX web server: an online force field. Nucleic Acids Res. 33, W382\u2013W388 (2005).","journal-title":"Nucleic Acids Res."},{"key":"68040_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.immuni.2007.01.012","volume":"26","author":"S Meixlsperger","year":"2007","unstructured":"Meixlsperger, S. et al. Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor. Immunity 26, 323\u2013333 (2007).","journal-title":"Immunity"},{"key":"68040_CR25","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1073\/pnas.1913810117","volume":"117","author":"PC Maity","year":"2020","unstructured":"Maity, P. C. et al. IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling. Proc. Natl. Acad. Sci. USA 117, 4320\u20134327 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68040_CR26","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","volume":"111","author":"A Lanemo Myhrinder","year":"2008","unstructured":"Lanemo Myhrinder, A. et al. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 111, 3838\u20133848 (2008).","journal-title":"Blood"},{"key":"68040_CR27","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3324\/haematol.2014.106054","volume":"99","author":"A-C Bergh","year":"2014","unstructured":"Bergh, A.-C. et al. Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia. Haematologica 99, 1722\u20131730 (2014).","journal-title":"Haematologica"},{"key":"68040_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.clim.2016.08.020","volume":"172","author":"K Hatzi","year":"2016","unstructured":"Hatzi, K. et al. Chronic lymphocytic leukemia immunoglobulins display bacterial reactivity that converges and diverges from auto-\/poly-reactivity and IGHV mutation status. Clin. Immunol. 172, 44\u201351 (2016).","journal-title":"Clin. Immunol."},{"key":"68040_CR29","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1182\/blood-2014-09-603217","volume":"125","author":"M Gounari","year":"2015","unstructured":"Gounari, M. et al. Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8. Blood 125, 3580\u20133587 (2015).","journal-title":"Blood"},{"key":"68040_CR30","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1182\/blood-2008-06-162024","volume":"112","author":"CC Chu","year":"2008","unstructured":"Chu, C. C. et al. Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA. Blood 112, 5122\u20135129 (2008).","journal-title":"Blood"},{"key":"68040_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2119\/2008-00102.Catera","volume":"14","author":"R Catera","year":"2008","unstructured":"Catera, R. et al. Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol. Med. 14, 665\u2013674 (2008).","journal-title":"Mol. Med."},{"key":"68040_CR32","doi-asserted-by":"publisher","first-page":"109956","DOI":"10.1016\/j.abb.2024.109956","volume":"754","author":"HB Ferreira","year":"2024","unstructured":"Ferreira, H. B. & Domingues, M. R. Oxidized phospholipid-protein adducts: the future targets of interest. Arch. Biochem. Biophys. 754, 109956 (2024).","journal-title":"Arch. Biochem. Biophys."},{"key":"68040_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaut.2017.06.004","volume":"84","author":"C Gr\u00f6nwall","year":"2017","unstructured":"Gr\u00f6nwall, C. et al. Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis. J. Autoimmun. 84, 29\u201345 (2017).","journal-title":"J. Autoimmun."},{"key":"68040_CR34","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1182\/blood-2007-02-073130","volume":"111","author":"GF Widhopf","year":"2008","unstructured":"Widhopf, G. F. et al. Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3. Blood 111, 3137\u20133144 (2008).","journal-title":"Blood"},{"key":"68040_CR35","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1182\/blood-2005-04-1511","volume":"106","author":"K Stamatopoulos","year":"2005","unstructured":"Stamatopoulos, K. et al. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood 106, 3575\u20133583 (2005).","journal-title":"Blood"},{"key":"68040_CR36","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1084\/jem.20112272","volume":"209","author":"JJ Taylor","year":"2012","unstructured":"Taylor, J. J. et al. Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen. J. Exp. Med. 209, 2065\u20132077 (2012).","journal-title":"J. Exp. Med."},{"key":"68040_CR37","doi-asserted-by":"publisher","first-page":"909","DOI":"10.4049\/jimmunol.175.2.909","volume":"175","author":"KL Hippen","year":"2005","unstructured":"Hippen, K. L. et al. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance. J. Immunol. 175, 909\u2013916 (2005).","journal-title":"J. Immunol."},{"key":"68040_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1084\/jem.20121801","volume":"210","author":"R Hoogeboom","year":"2013","unstructured":"Hoogeboom, R. et al. A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi. J. Exp. Med. 210, 59\u201370 (2013).","journal-title":"J. Exp. Med."},{"key":"68040_CR39","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/leu.2012.238","volume":"27","author":"R Hoogeboom","year":"2013","unstructured":"Hoogeboom, R. et al. A novel chronic lymphocytic leukemia subset expressing mutated IGHV3-7-encoded rheumatoid factor B-cell receptors that are functionally proficient. Leukemia 27, 738\u2013740 (2013).","journal-title":"Leukemia"},{"key":"68040_CR40","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/leu.2011.311","volume":"26","author":"E Kostareli","year":"2012","unstructured":"Kostareli, E. et al. Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4\u221259\/IGKV3-20 receptors with rheumatoid factor activity. Leukemia 26, 1127\u20131131 (2012).","journal-title":"Leukemia"},{"key":"68040_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1107\/S0907444911007773","volume":"67","author":"C Vonrhein","year":"2011","unstructured":"Vonrhein, C. et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D. Biol. Crystallogr. 67, 293\u2013302 (2011).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"68040_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D. Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"68040_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1107\/S0907444905036693","volume":"62","author":"P Evans","year":"2006","unstructured":"Evans, P. Scaling and assessment of data quality. Acta Crystallogr. D. Biol. Crystallogr 62, 72\u201382 (2006).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr"},{"key":"68040_CR44","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution?. Acta Crystallogr. D. Biol. Crystallogr. 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"68040_CR45","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1126\/science.1218231","volume":"336","author":"PA Karplus","year":"2012","unstructured":"Karplus, P. A. & Diederichs, K. Linking crystallographic model and data quality. Science 336, 1030\u20131033 (2012).","journal-title":"Science"},{"key":"68040_CR46","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr"},{"key":"68040_CR47","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1107\/S0907444997011980","volume":"54","author":"K Cowtan","year":"1998","unstructured":"Cowtan, K. & Main, P. Miscellaneous algorithms for density modification. Acta Crystallogr. D. Biol. Crystallogr. 54, 487\u2013493 (1998).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"68040_CR48","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"68040_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymeth.2011.07.005","volume":"55","author":"PD Adams","year":"2011","unstructured":"Adams, P. D. et al. The Phenix software for automated determination of macromolecular structures. Methods 55, 94\u2013106 (2011).","journal-title":"Methods"},{"key":"68040_CR50","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1107\/S0907444900014736","volume":"57","author":"MD Winn","year":"2001","unstructured":"Winn, M. D., Isupov, M. N. & Murshudov, G. N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D. Biol. Crystallogr. 57, 122\u2013133 (2001).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"68040_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"68040_CR52","doi-asserted-by":"publisher","first-page":"W314","DOI":"10.1093\/nar\/gkv314","volume":"43","author":"E Krissinel","year":"2015","unstructured":"Krissinel, E. Stock-based detection of protein oligomeric states in jsPISA. Nucleic Acids Res. 43, W314\u2013W319 (2015).","journal-title":"Nucleic Acids Res."},{"key":"68040_CR53","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1107\/S0567739476001873","volume":"32","author":"W Kabsch","year":"1976","unstructured":"Kabsch, W. A solution for the best rotation to relate two sets of vectors. Acta Cryst. A 32, 922\u2013923 (1976).","journal-title":"Acta Cryst. A"},{"key":"68040_CR54","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gky473","volume":"46","author":"W Tian","year":"2018","unstructured":"Tian, W., Chen, C., Lei, X., Zhao, J. & Liang, J. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 46, W363\u2013W367 (2018).","journal-title":"Nucleic Acids Res."},{"key":"68040_CR55","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/pro.3280","volume":"27","author":"E Jurrus","year":"2018","unstructured":"Jurrus, E. et al. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 27, 112\u2013128 (2018).","journal-title":"Protein Sci."},{"key":"68040_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-023-04927-7","volume":"6","author":"B Abanades","year":"2023","unstructured":"Abanades, B. et al. ImmuneBuilder: deep-Learning models for predicting the structures of immune proteins. Commun. Biol. 6, 1\u20138 (2023).","journal-title":"Commun. Biol."},{"key":"68040_CR57","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H Wardemann","year":"2003","unstructured":"Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374\u20131377 (2003).","journal-title":"Science"},{"key":"68040_CR58","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1172\/JCI24387","volume":"115","author":"M Herv\u00e9","year":"2005","unstructured":"Herv\u00e9, M. et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J. Clin. Invest. 115, 1636\u20131643 (2005).","journal-title":"J. Clin. Invest."},{"key":"68040_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-1-0716-4442-3_8","volume":"2909","author":"M Patrone","year":"2025","unstructured":"Patrone, M. & Degano, M. Recombinant production of B-cell receptor fab fragments from chronic lymphocytic leukemia in mammalian cells for structural and biochemical studies. Methods Mol. Biol. 2909, 103\u2013118 (2025).","journal-title":"Methods Mol. Biol."},{"key":"68040_CR60","doi-asserted-by":"publisher","first-page":"e25849","DOI":"10.4161\/cib.25849","volume":"6","author":"E Maza","year":"2013","unstructured":"Maza, E., Frasse, P., Senin, P., Bouzayen, M. & Zouine, M. Comparison of normalization methods for differential gene expression analysis in RNA-Seq experiments: a matter of relative size of studied transcriptomes. Commun. Integr. Biol. 6, e25849 (2013).","journal-title":"Commun. Integr. Biol."},{"key":"68040_CR61","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0006-3495(00)76713-0","volume":"78","author":"P Schuck","year":"2000","unstructured":"Schuck, P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 78, 1606\u20131619 (2000).","journal-title":"Biophys. J."},{"key":"68040_CR62","doi-asserted-by":"publisher","first-page":"771669","DOI":"10.3389\/fonc.2021.771669","volume":"11","author":"A Nicol\u00f2","year":"2021","unstructured":"Nicol\u00f2, A., Linder, A. T., Jumaa, H. & Maity, P. C. The determinants of B cell receptor signaling as prototype molecular biomarkers of leukemia. Front. Oncol. 11, 771669 (2021).","journal-title":"Front. Oncol."},{"key":"68040_CR63","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.4049\/jimmunol.1800690","volume":"202","author":"J Iype","year":"2019","unstructured":"Iype, J. et al. Differences in self-recognition between secreted antibody and membrane-bound B cell antigen receptor. J. Immunol. 202, 1417\u20131427 (2019).","journal-title":"J. Immunol."},{"key":"68040_CR64","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149308","volume":"132","author":"AN Mazzarello","year":"2022","unstructured":"Mazzarello, A. N. et al. B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia. J. Clin. Invest 132, e149308 (2022).","journal-title":"J. Clin. Invest"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68040-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68040-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68040-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:04:12Z","timestamp":1770120252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68040-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68040"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-68040-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1280"}}